RMRenata Martinelli

Renata Martinelli

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Renata Martinelli has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Focused Ultrasound-Mediated Blood–Brain Barrier Opening for Enhanced Drug Delivery in Diffuse Gliomas: A Systematic Review

    by Gabriele Ciaffi, Renata Martinelli, Andrea Traverso, Benedetta Burattini, Placido Bruzzaniti, Fabio Papacci, Andrea Talacchi, Giuseppe Maria della Pepa, Giovanni Pennisi

    Background/Objectives: The blood–brain barrier (BBB) severely limits the intratumoral delivery of systemically administered therapeutics in diffuse gliomas, including glioblastoma (GBM), contributing to the persistently poor prognosis of these tumors. Focused ultrasound (FUS) combined with microbubble agents enables transient, spatially targeted, and reversible BBB opening (BBBO), offering a non-invasive strategy to enhance drug delivery in this setting. Despite a rapidly growing body of clinical evidence, a systematic synthesis of outcomes across FUS platforms, drug regimens, and study designs is currently lacking. This systematic review aims to critically appraise the available clinical evidence on FUS-mediated BBBO for enhanced drug delivery in adult patients with diffuse gliomas. Methods: A systematic search of PubMed/MEDLINE and Scopus was performed using pre-specified search terms (last search: June 2026). Eligible studies included clinical trials and cohort studies enrolling adult patients (≥18 years) with histologically confirmed diffuse glioma (WHO grades II–IV) who underwent FUS-BBBO for therapeutic drug delivery enhancement. Two reviewers independently screened records and extracted data using a standardized form. Study quality was assessed using the NIH Quality Assessment Tool for Before-After Studies (single-arm studies) and the ROBINS-I tool (comparative studies). The review was retrospectively registered on OSF. Results were synthesized narratively due to study heterogeneity. Results: Eight publications from seven independent clinical studies were included. Across these publications, 68 patient entries were reported; however, because of overlapping populations across publications, the number of unique patients could not be precisely determined. Two FUS platforms were employed, with the ExAblate Neuro system (220–230 kHz) used in six out of seven cohorts. BBB opening was confirmed in all studies, with target sonication success rates of 92.4–100%. No procedure-related serious adverse events attributable to FUS-BBBO were reported across any study. Transient T2/SWAN hypointense foci were observed in a subset of patients, consistently asymptomatic and histologically benign. Direct intratumoral drug quantification was feasible in two pre-surgical studies, demonstrating a 2.2-fold increase in drug accumulation in FUS-treated versus untreated tissue (p < 0.01). The only comparative study reported a statistically significant improvement in overall survival (median 31.3 vs. 19.3 months; HR 0.50, p = 0.009) and progression-free survival (median 13.5 vs. 8.1 months; HR 0.55, p = 0.020) versus the controls. Conclusions: FUS-mediated BBBO is a safe and feasible approach for enhancing drug delivery in adult diffuse glioma patients across multiple platforms and drug combinations. Preliminary comparative data suggest a potential survival benefit in newly diagnosed GBM; however, these findings are based on a single non-randomized study and require confirmation in prospective randomized controlled trials.

  • Open Access

    Impact of Intraoperative Neurophysiological Monitoring on Supratentorial Meningioma Surgery: A Systematic Review

    by Martina Offi, Renata Martinelli, Benedetta Burattini, Michele Di Domenico, Francesca Annunziata, Francesco Pambianco, Rosa Linda Rinaldi, Vedant Vikram, Alessandro Izzo, Manuela D’Ercole, et al.

    Objectives: Our objective was to systematically evaluate the role of intraoperative neurophysiological monitoring (IONM) in supratentorial meningioma surgery, focusing on intraoperative changes, surgical decision-making, and postoperative neurological outcomes. Methods: A PRISMA-guided systematic review was conducted across PubMed, Scopus, and Cochrane databases. Nine studies, including 576 supratentorial meningioma (STM) cases identified across the source cohorts, were analyzed. Data extraction included study design, tumor location, monitoring modalities, intraoperative neurophysiological changes, and postoperative outcomes. Risk of bias was assessed using ROBINS-I, the JBI Critical Appraisal Checklist, or QUADAS-2, according to study design. Results: IONM modalities varied widely and included motor and somatosensory evoked potentials, cortical stimulation, and electromyography. Substantial heterogeneity was observed. Postoperative deficits occurred in both monitored and unmonitored patients (5.2–66%), including cases with preserved intraoperative signals, suggesting false negatives. IONM influenced intraoperative decision-making in selected cases, particularly for tumors near motor areas. However, its impact on postoperative outcomes remains unclear. Conclusions: Intraoperative motor cortex identification was the most consistently reported finding with a surgical impact. Available data from the literature are inconclusive about the role of IONM in reducing postoperative neurological morbidity.

  • Open Access

    Idiopathic Syringomyelia: A Systematic Scoping Review

    by Renata Martinelli, Luca Massimi

    Background: Idiopathic syringomyelia (IS) is defined by exclusion: an intramedullary fluid-filled cavity without Chiari malformation, spinal trauma, tumor, infection, or other identifiable cause. Growing evidence suggests IS is a progressively shrinking category as advanced imaging and intraoperative exploration uncover occult arachnoid or hydrodynamic substrates. To the best of our knowledge, no systematic reviews of the literature have been published on this topic. The authors aim to map operational definitions of IS, summarize proposed pathogenetic mechanisms, characterize diagnostic strategies and their yield, describe management approaches and outcomes, and identify pediatric–adult differences. Methods: A scoping review was conducted in accordance with PRISMA-ScR. PubMed and Scopus were searched from inception to May 2026. Eligible sources were original studies of any design addressing IS in pediatric or adult patients, in English. Studies on syringomyelia secondary to Chiari malformation, trauma, tumor, or infection were excluded. Data were extracted across five domains and synthesized narratively. Results: Eighteen studies (365 patients; five case reports, nine retrospective cohorts, two morphometric studies, one cine-MRI case–control, one technical note) were included. Operational definitions were markedly heterogeneous. Four pathogenetic mechanisms emerged: subarachnoid CSF obstruction with abnormal intramedullary pulse pressure, occult arachnoid pathology, posterior fossa morphometric variants overlapping with the Chiari spectrum, and persistent central canal as a developmental variant. In the four largest pediatric series (n = 214), 91–95% of children remained stable or improved on conservative management at up to 7-year follow-up, with no concordance between syrinx size change and clinical course. In symptomatic adults, targeted arachnoid lysis or web excision yielded clinical improvement in 87% of IS-occult arachnoid web patients; syringo-subarachnoid shunting was occasionally effective but risked neurological deterioration without prior substrate identification. Conclusions: The idiopathic label reflects the current limits of diagnostic investigation rather than a fixed nosological entity, since occult arachnoid or hydrodynamic substrates are identified in most adult IS cases when advanced imaging and intraoperative exploration are systematically deployed. Pathogenesis converges on a unified model of subarachnoid CSF obstruction generating abnormal intramedullary pulse pressure. Management should be driven by clinical, not radiological, evolution: arachnolysis or web excision is the primary strategy when an operable substrate is identified, while conservative management remains best supported in clinically stable patients, particularly children.

  • Open Access

    High-Frequency Spinal Cord Stimulation for the Treatment of Spasticity: A Preliminary Case Series

    by Alessandro Izzo, Benedetta Burattini, Renata Martinelli, Quintino Giorgio D’alessandris, Manuela D'Ercole, Maria Filomena Fuggetta, Nicola Montano

    Background: Spasticity is a complex and multifactorial condition resulting from upper motor neuron injury. It manifests through muscle contractions, pain, limited range of motion, and clonus, which significantly impair daily activities and quality of life. High-frequency spinal cord stimulation (HF SCS) has shown optimal results in treating chronic neuropathic pain, but its potential role in spasticity remains underexplored. This study aimed to evaluate the efficacy of HF SCS in patients with spasticity. Methods: From April 2021 to July 2024, six patients with spasticity from various etiologies underwent SCS implantation at our institution. Clinical evaluations including the use of the Visual Analog Scale (VAS), Douleur Neuropathique 4 (DN4), and the Ashworth score, as well as ambulation ability and clonus episodes, were performed preoperatively and at a minimum of six months post-surgery. Subjective assessments of motor function, including coordination, movement efficiency, and postural transitions, were also recorded. Results: The mean age of patients was 50.12 ± 9.41 years, with follow-up averaging 24.32 ± 10.83 months. Statistically significant improvements were observed in VAS (p = 0.0412) and DN4 (p = 0.0422) scores, alongside a reduction in clonus episodes. All patients reported subjective improvements in coordination, movement efficiency, and postural transitions. Ambulation remained stable or improved in all cases. No perioperative complications or sensory/motor side effects were noted. Conclusions: HF SCS offers a promising approach to managing spasticity, with improvements in motor function, ambulation, and postural transitions. These findings support further investigation into HF SCS for spasticity, with multicenter trials needed to optimize treatment protocols and identify the most responsive patient populations.


  • Open Access

    Advancing White Matter Knowledge in Neurosurgical Training: Validation and Educational Impact of a Novel 3-Dimensional–Printed Simulator

    by Grazia Menna, Dora Riva, Carlotta Ranalli, Salvatore Marino, Renata Martinelli, Alessandro Olivi, Francesco Doglietto, Giannantonio Spena, Federico Nicolosi, Giuseppe Maria Della Pepa


  • Open Access

    Improving Outcomes and Preventing Complications in Cranial Base Surgery

    by Nicola Montano, Renata Martinelli, Joao Paulo Almeida

    Skull base surgery has evolved remarkably since the pioneering techniques of early 20th-century surgeons, such as Schloffer and Cushing, who laid the foundation for transcranial and transnasal approaches


  • Open Access

    Optimizing surgical technique in microvascular decompression for hemifacial spasm – Results from a surgical series with contemporary use of neuronavigation and intraoperative neuromonitoring

    by Marco Battistelli, Alessandro Izzo, Manuela D’eRcole, Quintino Giorgio D’aLessandris, Michele Di Domenico, Eleonora Ioannoni, Camilla Gelormini, Renata Martinelli, Federico Valeri, Fulvio Grilli, et al.

    Background: Microvascular decompression (MVD) through a retrosigmoid approach is considered the treatment of choice in cases of hemifacial spasm (HFS) due to neurovascular conflict (NVC). Despite the widespread of neuronavigation and intraoperative neuromonitoring (IONM) techniques in neurosurgery, their contemporary application in MVD for HFS has been only anecdotally reported.Methods: Here, we report the results of MVD performed with a combination of neuronavigation and IONM, including lateral spread response (LSR) in 20 HFS patients. HFS clinical outcome and different surgical-related factors, such as craniotomy size, surgical duration, mastoid air cell (MAC) opening, postoperative cerebral spinal fluid (CSF) leakage, sinus injury, and other complications occurrence, and the length of hospitalization (LOS) were studied.Results: Postoperatively, residual spasm persisted only in two patients, but at the latest follow-up (FU) (mean: 12.5 ± 8.98 months), all patients had resolution of symptoms. The mean surgical duration was 103.35 ± 19.36 min, and the mean LOS was 2.21 ± 1.12 days. Craniotomy resulted in 4.21 ± 1.21 cm2in size. Opening of MAC happened in two cases, whereas no cases of CSF leak were reported as well as no other complications postoperatively and during FU.Conclusion: MVD for HFS is an elective procedure, and for this reason, surgery should integrate all technologies to ensure safety and efficacy. The disappearance of LSR is a crucial factor for identifying the vessel responsible for NVC and for achieving long-term resolution of HFS symptoms. Simultaneously, the benefits of using neuronavigation, including the ability to customize the craniotomy, contribute to reduce the possibility of complications.


  • Open Access

    Long-Term Outcome in Adult Patients with Drug-Resistant Epilepsy Submitted to Vagus Nerve Stimulation

    by Samuele Santi, Filomena Fuggetta, Gabriella Colicchio, Manuela D’ercole, Alessandro Izzo, Quintino Giorgio D’alessandris, Benedetta Burattini, Renata Martinelli, Nicola Montano

    Epilepsy treatment primarily involves antiseizure medications (ASMs) to eliminate seizures and improve the quality of life, but many patients develop drug-resistant epilepsy (DRE), necessitating alternative interventions. This study aimed to evaluate the long-term efficacy and safety of vagus nerve stimulation (VNS) in managing DRE. We retrospectively analyzed data from 105 adult patients treated at Agostino Gemelli Hospital from 1994 to 2022. Among the 73 patients with follow-up data, 80.8% were responders, experiencing significant reductions in seizure frequency over an average follow-up period of 9.4 years. Although 19.2% were non-responders, many of these patients still opted for generator replacements due to improvements in quality of life, such as fewer falls and shorter post-ictal periods. The overall complication rate was 12.3%, with most complications being mild and manageable. These findings suggest that VNS offers substantial long-term benefits for patients with DRE, improving seizure control and quality of life. This study underscores the importance of VNS as a viable long-term treatment option for DRE, highlighting its potential to significantly enhance patient outcomes and quality of life.


  • Open Access

    Outcome Comparison of Drug-Resistant Trigeminal Neuralgia Surgical Treatments—An Umbrella Review of Meta-Analyses and Systematic Reviews

    by Alessandro Rapisarda, Marco Battistelli, Alessandro Izzo, Manuela D’ercole, Quintino Giorgio D’alessandris, Filippo Maria Polli, Samuele Santi, Renata Martinelli, Nicola Montano

    Medical treatment for trigeminal neuralgia (TN) is not always a feasible option due to a lack of full response or adverse effects. Open surgery or percutaneous procedures are advocated in these cases. Several articles have compared the results among different techniques. Nevertheless, the findings of these studies are heterogeneous. Umbrella reviews are studies sitting at the peak of the evidence pyramid. With this umbrella review, we provided a systematic review of the outcomes of the surgical procedures used for TN treatment. Only systematic reviews and meta-analyses were included following the PRISMA guidelines. Ten articles were enrolled for qualitative and quantitative assessment. Level of evidence was quantified using a specific tool (AMSTAR-2). Results were heterogenous in terms of outcome and measurements. Microvascular decompression (MVD) appeared to be the most effective procedure both in the short-term (pain relief in 85–96.6% of cases) and long-term follow-up (pain relief in 64–79% of cases), although showed the highest rate of complications. The results of percutaneous techniques were similar but radiosurgery showed the highest variation in term of pain relief and a higher rate of delayed responses. The use of the AMSTAR-2 tool to quantify the evidence level scored three studies as critically low and seven studies as low-level, revealing a lack of good quality studies on this topic. Our umbrella review evidenced the need of well-designed comparative studies and the utilization of validated scales in order to provide more homogenous data for pooled-analyses and meta-analyses in the field of TN surgical treatment.